Ran Lin Selected Research

Neoplasm Metastasis (Metastasis)

1/2020	Supramolecular Tubustecan Hydrogel as Chemotherapeutic Carrier to Improve Tumor Penetration and Local Treatment Efficacy.
1/2018	Rational design of multimodal therapeutic nanosystems for effective inhibition of tumor growth and metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ran Lin Research Topics

Disease

7	Neoplasms (Cancer) 10/2020 - 01/2016
4	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2016
2	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2018
2	Congenital Abnormalities (Deformity) 01/2023 - 12/2022
2	Multiple Hereditary Exostoses (Hereditary Multiple Exostoses) 01/2023 - 12/2022
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2022 - 01/2022
2	Wounds and Injuries (Trauma) 11/2021 - 11/2020
2	Glioblastoma (Glioblastoma Multiforme) 10/2020 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
1	Lung Diseases (Lung Disease) 07/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2023
1	Lung Injury 07/2023
1	Inflammation (Inflammations) 07/2023
1	Humeral Fractures 02/2023
1	Fibrosis (Cirrhosis) 12/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2022
1	Postoperative Hemorrhage 11/2020
1	Femoral Neck Fractures 11/2020
1	Stroke (Strokes) 12/2019
1	Obesity 10/2019
1	Rheumatoid Arthritis 01/2017
1	Glioma (Gliomas) 01/2017
1	Alcoholism (Alcohol Abuse) 08/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014

Drug/Important Bio-Agent (IBA)

5	HydrogelsIBA 11/2021 - 01/2017
4	Peptides (Polypeptides)IBA 11/2021 - 01/2016
4	ProdrugsIBA 10/2020 - 01/2016
3	CamptothecinIBA 10/2020 - 01/2016
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2020 - 01/2016
1	Mediator ComplexIBA 03/2024
1	ChromatinIBA 03/2024
1	RNA Polymerase II (RNA Polymerase B)IBA 03/2024
1	Estrogen ReceptorsIBA 03/2024
1	InflammasomesIBA 07/2023
1	Interleukin-6 (Interleukin 6)IBA 07/2023
1	CatalaseIBA 07/2023
1	schizandrin AIBA 07/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2023
1	Malondialdehyde (Propanedial)IBA 07/2023
1	Heme Oxygenase-1IBA 07/2023
1	Superoxide DismutaseIBA 07/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2023
1	SmokeIBA 07/2023
1	Bone Morphogenetic Protein 4IBA 12/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2022
1	AngiotensinsIBA 09/2022
1	Losartan (Cozaar)FDA LinkGeneric 09/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Valsartan (Vals)FDA Link 11/2021
1	SolutionsIBA 10/2020
1	Cyclic PeptidesIBA 01/2020
1	Drug CarriersIBA 01/2020
1	PolymersIBA 01/2020
1	Peptide Elongation Factor G (EF G)IBA 12/2019
1	Messenger RNA (mRNA)IBA 12/2019
1	N-methyl-N-styrylcinnamamideIBA 10/2019
1	PolyethyleneimineIBA 01/2018
1	GoldIBA 01/2018
1	EnzymesIBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	DisulfidesIBA 01/2018
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	AcidsIBA 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	LigandsIBA 01/2016
1	Ethanol (Ethyl Alcohol)IBA 08/2015
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2014

Therapy/Procedure

3	Therapeutics 10/2020 - 01/2018
2	Distraction Osteogenesis 01/2023 - 12/2022
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2018
1	Bone Wires 02/2023
1	Treatment Delay 02/2023
1	External Fixators 12/2022
1	Osteotomy 12/2022
1	Hemiarthroplasty 11/2020
1	Blood Transfusion (Blood Transfusions) 11/2020
1	Injections 01/2017